2021
2021
Clinical validation studies started at Oslo Metropolitan University
2021
2021
Application for national patent on all Spermosens target markets globally
2020
Application for national patent in EU according to PACE programme for rapid entry
2020
2020
Bull study at University in Murcia confirming JUNO as essential biomarker for male fertility
2020
Preliminary Report on Patentability (IPRP)
European Patent Office acknowledges novelty, inventive step and industrial applicability.
2020
2020
Spermosens becomes members of SmiLe Incubator
2020
Spermosens gets laboratory facility at Medicon Village
2020
2020
John Lempert joins as the CEO
Kush starts as the CSO2020
Spermosens receives support from Innovation Skåne
2020
2020
Spermosens moves into The Spark, Medicon Village
2019
Biosensor developed
2019
2019
Proprietary JUNO and ZP3 proteins produced
2019
Spermosens receives support from Vinnova
2019
2018
Foundation of Spermosens
2018
First patent application filed
2018
2018
JUNO reported on human oocytes
2014
Discovery of JUNO in mammals
2014
2014
Early prototype with ZP3 established
2012
Kush Punyani and Prof Sudha Srivastava conceptualise a fertility testing device
2012
